Partnership Opportunities

We partnered with cutting-edge service providers with capabilities in chemoproteomics, mass spectrometry, computational biology tools, and assay development for small molecule drug developers with the goal of uniting the industry to overcome existing challenges in this emerging space and unlock the potential of small molecule drugs.

If you have relevant capabilities and are looking to collaborate with the key decision makers in the proteomics space, contact us to register interest to promote your services and solutions through a bespoke commercial package at next year's event.

Why Did Our Partners Choose Us?

• They expanded their networking horizons by meeting 80+ Directors, Heads & Principal Scientists of Proteomics, Chemical Biology and Chemoproteomics across 3-days with 10+ hours of dedicated networking time to raise awareness for their proteomics services.
• They promoted their brand to powerhouses and newcomers alike, including Novartis, Biogen, Sanofi, Covant Therapeutics, Rezo Therapeutics and many more.
• They conducted meaningful interactions and generated commercial opportunities with 7+ hours of built-in networking time with VPs, Directors, and Heads of Proteomics, Chemical Biology, Chemoproteomics and more.